uPath HER2 (4B5) image analysis, Breast (CE-IVD)

Ready-to-use, fast, consistent and automated algorithm for clinical decision support

uPath HER2 image analysis breast (CE-IVD) product

uPath image analysis algorithms

An intelligent and insightful digital pathology solution requires image analysis tools that empower pathologists to confidently and objectively assess whole tissue slide images. The uPath HER2 (4B5) image analysis for Breast algorithm is intended for use as an aid to the pathologist in the semi-quantitative detection of HER2 protein in formalin-fixed, paraffin-embedded neoplastic breast tissue. When used with the VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody, it is indicated for use as an aid in the assessment of breast cancer patients for whom Herceptin® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine) or PERJETA® (pertuzumab) treatments are being considered.

uPath HER2 (4B5) image analysis, Breast features
  • Pathologist trained artificial intelligence: Resulting in objective and reproducible scoring of VENTANA DP 200 slide images stained with the VENTANA HER2 (4B5) assay
  • Integrated into the clinical uPath software: Seamless viewing, aligning and syncing functionality, sharing capabilities, and reporting
  • Whole slide analysis (WSA): Automated pre-computing of the slide image prior to pathologist assessment, providing fast results for user-defined regions of interest (ROI)
  • Quick automated scoring: Quickly calculates HER2 score
  • Clear visual overlay: Highlighting positively stained membrane for easy reference

Integrated and ready-to-use

Validated for use with the VENTANA HER2 (4B5) assay for use within Roche uPath enterprise software.

Quick and automated

Pathologist trained artificial intelligence algorithm for quick image analysis.

Accurate, consistent and confident

Actionable assessment of scanned slide images that are objective and reproducible, aiding in informing on potential treatment strategies.